①原著（筆頭著者のイニシアル順）
| 1. |
Ando J*, Saito M*, Imai J, Ito E, Yanagisawa, Honma R, Saito K*, Tachibana K, Momma T*, Ohki S*, Ohtake T, Watanabe S, Waguri S, Kono K*,Takenoshita S. TBX19 is overexpressed in colorectal cancer and associated with lymph node metastasis. Fukushima J Med Sci. 63(3): 141-151, 2017. |
| 2. |
George J, Saito M*, Tsuta K, Iwakawa R, Shiraishi K, Scheel AH, Uchida S, Watanabe SI, Nishikawa R, Noguchi M, Peifer M, Jang SJ, Petersen I, Buttner R, Harris CC, Yokota J, Thomas RK, Kohno T. (co-first author) Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 23(5):1220-1226, 2017. |
| 3. |
Gonda K*, Shibata M*, Ohtake T, Matsumoto Y, Tachibana K, Abe N, Ohto H, Sakurai K, Takenoshita S. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncol Lett. 14(2):1766-1774, 2017. |
| 4. |
Gonda K, Shibata M, Sato Y, Washio M, Takeshita H, Shigeta H, Ogura M, Oka S, Sakuramoto S. Elevated neutrophil to lumphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S-1 plus cisplatin, and poor prognosis in patients with stage IV gastric cancer. Mol Clin Oncol. 7(6): 1073-1078, 2017. |
| 5. |
Goto A, Tanaka M, Yoshida M, Umakoshi M, Nanjo H, Shiraishi K, Saito M*, Kohno T, Kuriyama S, Konno H, Imai K, Saito H, Minamiya Y, Maeda D. The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases. PLoS One. 12(7):e0181270, 2017. |
| 6. |
Hayase S*, Kumamoto K*, Saito K*, Kofunato Y, Sato Y*, Okayama H*, Miyamoto K*, Ohki S*, Takenoshita S. L?type amino acid transporter 1 expression is upregulated and associated with cellular proliferation in colorectal cancer. Oncol Lett. 14(6): 7410-7416, 2017. |
| 7. |
Hayashi H, Kohno T, Ueno H, Hiraoka N, Kondo S, Saito M*, Ichikawa H, Kato M, Shibata T, Morizane C, Sakamoto T, Shimada K, Komatsu Y, Sakamoto N, Okusaka T. The number of mutations among KRAS, CDKN2A, TP53, and SMAD4 as detected using targeted deep sequencing is a useful prognostic biomarker for pancreatic cancer. Pancreas 46(3):335-340, 2017. |
| 8. |
Kasai N, Sasakawa A, Hosomi K, Poh TW, Chua BL, Yong WP, So J, Chan SL, Soong R, Kono K*, Ishii T, Yamano K. Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancer. Am J Transl Res. 9(7):3399-3410, 2017. |
| 9. |
Kogashiwa Y, Yasuda M, Sakurai H, Nakahira M, Sano Y, Gonda K*, Ikeda T, Inoue H, Kuba K, Oba S, Ishikawa J, Enoki Y, Matsumura S, Minami K, Ebihara Y, Sugasawa M. PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma. Anticancer Res. 37(3):1417-1424, 2017. |
| 10. |
Kumamoto K, Endo S, Isohata N, Nirei A*, Nemoto D, Utano K, Saito T, Togashi K. Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases. Mol Clin Oncol. 6(1):63-66, 2017. |
| 11. |
Kunisaki C, Miyata H, Konno H, Saze Z*, Hirahara N, Kikuchi H, Wakabayashi G, Gotoh M, Mori M. Modeling preoperative risk factors for potentially lethal morbidities using a nationwide Japanese web-based database of patients undergoing distal gastrectomy for gastric cancer. Gastric Cancer. 20(3):496-507, 2017. |
| 12. |
Minamikawa K, Shibata M*, Gonda K*, Ujiie D*, Ashizawa M*, Nakajima T*, Okayama H*, Sakamoto W*, Saito M*, Momma T*, Mimura K* , Ohki S*, Shimura T, Ohto H, Takenoshita S, Kono K*. IL-17 and VEGF are significantly associated with disease progression involving systemic inflammation in patients with gastric and colorectal cancers. Ann. Cancer Res. Ther. 25(2):67-76, 2017. |
| 13. |
Mimura K*, Kua LF, Shimasaki N, Shiraishi K, Nakajima S, Siang LK, Shabbir A, So J, Yong WP, Kono K*. Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress. Cancer Immunol Immunother. 66(5):605-613, 2017. |
| 14. |
Mimura K*, Teh JL, Okayama H*, Shiraishi K, Kua LF, Koh V, Smoot DT, Ashktorab H, Oike T, Suzuki Y, Fazreen Z, Asuncion BR, Shabbir A, Yong WP, So J, Soong R, Kono K*. PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Sci. 2018 Jan;109(1):43-53. doi: 10.1111/cas.13424. Epub 2017 Nov 18. |
| 15. |
Momma T*, Okayama H*, Saitou M*, Sugeno H*, Yoshimoto N*, Takebayashi Y, Ohki S*, Takenoshita S. Expression of circadian clock genes in human colorectal adenoma and carcinoma. Oncol Lett. 14(5):5319-5325, 2017. |
| 16. |
Ohkouchi C, Kumamoto K, Saito M*, Ishigame T, Suzuki SI, Takenoshita S, Harris CC. ING2, a tumor associated gene, enhances PAI1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C terminal. Mol Med Rep. 16(5):7367-7374, 2017. |
| 17. |
Onozawa H*, Saito M*, Saito K*, Kanke Y*, Watanabe Y*, Hayase S*, Sakamoto W*, Ishigame T, Momma T*, Ohki S*, Takenoshita S. Annexin A1 is involved in resistance to 5-FU in colon cancer cells. Oncology Rep. 37(1):235-240, 2017. |
| 18. |
Saito M*, Fujiwara Y, Asao T, Honda T, Shimada Y, Kanai Y, Tsuta K, Kono K*, Watanabe S, Ohe Y, Kohno T. The genomic and epigenomic landscape in thymic carcinoma. Carcinogenesis, 38(11):1084-1091, 2017. |
| 19. |
Saito M*, Okayama H*, Saito K*, Ando J, Ohki S*, Ishii Y, Takenoshita S. CDX2 is involved in microRNA-related inflammatory carcinogenesis in gastric cancer. Oncol Lett. 14(5):6184-6190, 2017. |
| 20. |
Sato H, Niimi A, Yasuhara T, Permata TBM, Hagiwara Y, Isono M, Nuryadi E, Sekine R, Oike T, Kakoti S, Yoshimoto Y, Held KD, Suzuki Y, Kono K*, Miyagawa K, Nakano T, Shibata A. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells. Nat Commun. 8(1):1751, 2017 |
| 21. |
Sato Y, Gonda K*, Harada M, Tanisaka Y, Arai S, Mashimo Y, Iwano H, Sato H, Ryozawa S, Takahashi T, Sakuramoto S, Shibata M*. Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma. Biomed Rep. 7(1):79-84, 2017. |
| 22. |
Shimura T, Shibata M*, Gonda K*, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Marubashi S, Kono K*, Takenoshita S. Clinical Significance of Soluble Intercellular Adhesion Molecule-1 and Interleukin-6 in Patients with Extrahepatic Cholangiocarcinoma. J Invest Surg. 19:1-8. 2017. |
| 23. |
Shimura T, Shibata M*, Gonda K*, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Kono K*, Marubashi S. Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer. Anticancer Res. 37(9):4979-4986, 2017. |
| 24. |
Tachibana K, Saito M*, Imai J, Ito E, Yanagisawa, Honma R, Saito K, Ando J, Momma T*, Ohki S*, Ohtake T, Watanabe S, Waguri S and Takenoshita S. Clinicopathological examination on DPEP1 expression in colorectal cancer. Biomed Rep. 6(4):423-428, 2017. |
| 25. |
Tachibana K, Shibata M, Gonda K, Matsumoto Y, Nakajima T, Abe N, Ohtake T, Shimura T, Ohto H, Kono K and Takenoshita S. IL-17 and vascular endothelial growth factor (VEGF) are increased and correlated to systemic inflammation, immune suppression and malnutrition in patients with breast cancer. European J of Inflammation, 20: 1-10, 2017 |
| 26. |
Tada T*, Honma R, Imai JI, Saze Z*, Kogure M, Marubashi S, Tasaki K, Unakami M, Ezaki J, Tamura H, Nishikawa A, Hashimoto Y, Waguri S, Watanabe S, Gotoh M. A novel gene expression scoring system for accurate diagnosis of basaloid squamous cell carcinoma of the esophagus. Int J Oncol. 51(3):877-886, 2017. |
| 27. |
Zhu L, Rossi M, Cui Y, Lee RJ, Sakamoto W*, Perry NA, Urs NM, Caron MG, Gurevich VV, Godlewski G, Kunos G, Chen M, Chen W, Wess J. Hepatic β-arrestin 2 is essential for maintaining euglycemia. J Clin Invest. 127(8):2941-2945, 2017. |
| 28. |
Zhu L, Almaca J, Dadi PK, Hong H, Sakamoto W*, Rossi M, Lee RJ, Vierra NC, Lu H, Cui Y, McMillin SM, Perry NA, Gurevich VV, Lee A, Kuo B, Leapman RD, Matschinsky FM, Doliba NM, Urs NM, Caron MG, Jacobson DA, Caicedo A, Wess J. β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions. Nat Commun. 8:14295, 2017. |
